The Importance of Regulating E-Cigarettes in Ireland

Jul.31.2022
The Importance of Regulating E-Cigarettes in Ireland
The Irish tobacco policy group chair supports restricting e-cigarettes to promote public health and reduce teen smoking.

Professor Des Cox, the chairman of the Irish Tobacco Policy Group, has commented on the recent opinion piece in the Wall Street Journal titled "Why We Shouldn't Wage War on E-cigarettes", stating that he believes such a battle should indeed be fought.


In 2013, the government launched a bold plan to reduce Ireland's smoking rate to 5% by 2025, ushering in a smoke-free society. As of 2021, however, 18% of Irish adults are still smokers, rendering this ambitious goal unattainable.


Last week's opinion piece argued that Ireland needs to embrace e-cigarettes to help more people quit smoking, but is there evidence to support this approach?


The Oireachtas Health Committee has released a report on the Public Health (Tobacco and Nicotine Inhaling Products) Bill. In addition to recommending a ban on the sale of electronic cigarettes to those under 18, the committee also suggested prohibiting the sale of all flavors except tobacco, introducing plain packaging, and banning all forms of e-cigarette advertising.


Teenagers


The first issue to be addressed is the relationship between electronic cigarettes and youth. According to the findings report from the European School Survey Project on Alcohol and Other Drugs (ESPAD) released by the TobaccoFree Research Institute in 2020, the use of electronic cigarettes by 16-17 year-olds has increased by 50% since 2015.


According to a recent survey by ASH UK, 39% of teenagers have tried e-cigarettes and 18% are current users. The study also found that the number of children aged 11 to 17 who use e-cigarettes has increased from 11.2% in 2021 to 15.7% in 2022.


Of concern is the simultaneous increase in the use of electronic cigarettes and the consumption of disposable e-cigarette products by young people. According to a report, the use of disposable e-cigarettes by this age group has increased seven-fold from 2020 to 2022. Nearly half of the surveyed teenagers reported seeing e-cigarette promotion and specifically on TikTok. There is an urgent need to strengthen regulations around the marketing of e-cigarettes, especially online marketing.


Last week's article raised concerns that banning flavored e-cigarettes would result in an increase in Ireland's smoking population. However, there is no publicly available evidence to support this claim. On the other hand, there is substantial evidence indicating that flavored products attract young people to purchase them, leading them to believe that e-cigarettes are a harmless product.


Although adults may also be attracted to flavored electronic cigarettes, the risks of teenagers and young people starting to use them may outweigh the benefits of former smokers using flavored electronic cigarettes.


Last week's article claimed that vaping is a gateway to smoking. A comprehensive study on the topic has found that teenagers who have used e-cigarettes are three to five times more likely to start smoking compared to those who have never used e-cigarettes.


There is now irrefutable evidence that we must protect children from the lure of smoking and e-cigarettes. Simply banning the sale of e-cigarettes to children under the age of 18 through the proposed public health bill will not be the ultimate solution; government officials need to consider the recommendations of the Oireachtas committee on the bill.


Based on the available evidence, we suggest that electronic cigarettes should be subject to the same packaging, advertising, and marketing restrictions as traditional tobacco products. Ireland should only allow tobacco-flavored e-cigarettes, which would enable former smokers to continue experiencing the taste of tobacco while limiting their use among adolescents and young adults.


Last year, a systematic review was published which analyzed ten randomized controlled trials to investigate whether electronic cigarettes were an effective tool for smoking cessation. The review found no evidence to suggest that electronic cigarettes were more effective than nicotine replacement therapy (NRT), which is approved and regulated for smoking cessation.


The evidence for electronic cigarettes as a tool for quitting smoking is at best mixed, and healthcare professionals should recommend reliable methods such as NRT that have been proven effective through practice, rather than electronic cigarettes. In January, Ireland released its first national smoking cessation guidelines, which did not recommend electronic cigarettes as a tool for quitting smoking due to insufficient evidence and the uncertainty surrounding these products.


Best advice.


In addition, healthcare professionals need to have confidence that the treatments they recommend to patients are safe in order to suggest effective methods of care. In 2020, the Health Research Council conducted a review of over 361 studies on the risks and benefits of e-cigarettes and found that they have negative effects on the heart and lungs.


Some supporters of using e-cigarettes as a tool to quit smoking claim that they are 95% safer than tobacco products. However, this statement lacks scientific evidence and is based on the opinions of a small group of doctors from 2013, when we knew little about the harmful effects of e-cigarettes. While it is important to acknowledge that e-cigarettes pose less harm than tobacco products, they are not without risk and the public needs to be aware of this fact.


The argument that e-cigarettes reduce harm has been overemphasized, as they are not more effective than validated treatment methods, and there is too much uncertainty regarding their long-term safety. Additionally, research indicates that many e-cigarette users continue smoking. The 2018 Healthy Ireland survey revealed that 4 out of every 10 adults who use e-cigarettes also use traditional cigarettes.


In order for electronic cigarettes to become a viable option in harm reduction strategies, they must prove themselves as safe products regulated by the Health Products Regulatory Authority (HPRA) to aid people in quitting smoking.


In summary, the evidence in 2022 does not support the argument that electronic cigarettes are an effective tool for quitting smoking. Their long-term safety is still a cause for serious concern and it has been proven that they are a gateway to smoking for teenagers.


Until more conclusive research becomes available, healthcare professionals should promote safe and effective smoking cessation methods, such as nicotine replacement therapy (NRT), rather than unproven methods like electronic cigarettes. The good news is that most smokers want to quit, and there is help available. The HSE's www.quit.ie service is staffed by experienced and trained professionals who offer validated smoking cessation assistance.


Note: Professor Des Cox serves as the Chair of the Tobacco Policy Group at the Royal College of Physicians of Ireland and as a Respiratory Medicine Consultant at Crumlin Children's Hospital in Ireland.


I am sorry, as an AI language model, I only perform tasks based on a specific prompt or request. Please provide me with the text that needs to be translated to standard journalistic English.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine's Cabinet of Ministers adopted Resolution No. 1259 on October 15, 2026, increasing excise stamp production fees for tobacco products and e-cigarette liquids by approximately 30.5%, from UAH 0.1643 to UAH 0.2144 per stamp. Fees for alcoholic beverages rose by about 30.2%. Separately, Ukraine's parliament passed Bill No. 15532 on October 13, proposing to postpone the full implementation of electronic excise stamps and traceability for alcohol, tobacco and e-cigarette liquids from November 1, 2026, to July 1, 2027. Parliament cited additional testing, configuration and integration requirements. The bill was sent to the president for signature on October 19.
Regulations
Oct.21
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy's proposed 2027–2029 budget would bring forward scheduled tax increases for e-cigarette liquids and heated tobacco products from January 1, 2028, to July 1, 2027. The consumption tax coefficient for nicotine-containing e-liquids would rise from 20% to 22%, that for nicotine-free liquids and applicable flavorings from 15% to 17%, and the heated-tobacco coefficient from 41% to 42%. The bill would also introduce official retail price schedules for e-liquids, restrict exclusive agreements between retailers and suppliers, and limit single-brand-dominated displays, sales incentives and bundled offers. Importing, authorized warehousing and retailer sourcing arrangements would also change. The proposals remain subject to parliamentary approval and subsequent implementing regulations.
Regulations
Nov.04
DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
Combined tobacco and vaping sales in UK convenience stores fell 10.6% year over year in the first half of 2026, making the category a major drag on channel performance, according to retail research organization IGD. Total convenience sales declined 1.2%, while sales excluding tobacco and vaping increased 0.7%. IGD's 2026 category-share figures show tobacco and vaping accounting for 15.4% of convenience sales, compared with 15.1% for alcohol. The organization forecasts alcohol could overtake tobacco and vaping as the largest category by sales value as early as 2027 if current trends continue. IGD expects the convenience market to increase from £48.6 billion in 2026 to £54.9 billion in 2031, a 2.5% compound annual growth rate, or 3.4% excluding tobacco and vaping.
DATA
Nov.11
Iowa's First Vape Directory Lists JUUL and Vuse Pod Systems Alongside Loon and Crossbar Disposables, With 20,000-Puff Products Listed Across States
Iowa's First Vape Directory Lists JUUL and Vuse Pod Systems Alongside Loon and Crossbar Disposables, With 20,000-Puff Products Listed Across States
Iowa published its first vapor products directory on November 16, 2026, listing 361 product entries, including 175 covering prefilled pods, devices, kits and disposable e-cigarettes. Established tobacco-company brands such as JUUL and Vuse appear alongside independent disposable brands including Loon, Crossbar and Z Stick. The products range from traditional small-capacity disposables to Crossbar's 13mL, 20,000-puff devices. Of the 361 records, 288 are marked FDA Pending. Both Crossbar entries were dated November 16 and carry UPCs also found in other state directories. By contrast, a matching Z Stick product lost its active Louisiana listing after its certification was not renewed.
Regulations
Nov.17
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05